Galena Biopharma, Inc.
(NASDAQ : GALE)

( )
GALE After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
1.02%73.340.9%$603.58m
CELGCelgene Corporation
2.24%130.291.1%$443.49m
AMGNAmgen Inc.
1.14%170.071.1%$408.88m
BIIBBiogen Inc.
1.26%286.721.2%$356.69m
REGNRegeneron Pharmaceuticals, Inc.
1.90%478.652.7%$320.91m
VRTXVertex Pharmaceuticals Incorporated
4.34%155.481.9%$240.46m
ALXNAlexion Pharmaceuticals, Inc.
3.58%138.201.9%$220.20m
ILMNIllumina, Inc.
2.14%194.763.5%$214.91m
INCYIncyte Corporation
2.46%123.862.6%$133.37m
KITEKite Pharma, Inc.
1.52%135.9516.1%$128.55m
CLVSClovis Oncology, Inc.
1.24%72.0818.0%$127.98m
TSROTESARO, Inc.
1.48%120.6214.7%$126.99m
AAgilent Technologies, Inc.
1.93%62.931.5%$121.42m
BMRNBioMarin Pharmaceutical Inc.
1.07%81.464.4%$105.18m
SRPTSarepta Therapeutics, Inc.
3.41%36.9519.8%$99.21m

Company Profile

Galena Biopharma, Inc. is a biopharmaceutical company committed to the development and commercialization of hematology and oncology therapeutics that address unmet medical needs. It focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA.